The Norwegian FSA fined a Norwegian issuer NOK 10 million for unlawfully disclosing inside information during pre-close analyst calls in March 2025. The disclosures breached the Market Abuse Regulation and securities law, fell outside the scope of ordinary business conduct, and disregarded recommendations from both ESMA and Oslo Børs.
pThe Norwegian FSA has concluded that a Norwegian issuer unlawfully disclosed inside information during pre-close calls with analysts in March 2025, in breach of Article 14(c) of the Market Abuse Regulation (MAR) and Section 3-1 of the Norwegian Securities Trading Act. The information concerned consensus estimates and expectations for EBITDA, revenues, and segment results. It was non-public, of a precise nature and price sensitive.
The Norwegian FSA determined that the dissemination was not part of the ordinary conduct of the company's business and highlighted that the issuer failed to follow both ESMA's recommendations on good practices for pre-close calls and Oslo Børs' investor relations guidelines.
As a result, the Norwegian FSA has imposed an administrative fine of NOK 10 million, which the issuer has accepted.
The Norwegian FSA noted in its decision that, given the issuer's size and market cap, it should have demonstrated a stronger understanding of the regulations governing the disclosure of inside information - regardless of context.
The case offers valuable insight into where national competent authorities are likely to draw the line on the disclosure of inside information during pre-close calls.
For more information about the case, seehere (in Norwegian)
To read ESMA's recommendation, clickhere
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
